{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:11:10Z","timestamp":1776870670436,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012706","name":"Uniwersytet Warmi\u0144sko-Mazurski w Olsztynie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006817","name":"University of Wisconsin-Milwaukee","doi-asserted-by":"publisher","award":["101x394"],"award-info":[{"award-number":["101x394"]}],"id":[{"id":"10.13039\/100006817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jchromb.2022.123516","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T18:56:12Z","timestamp":1667069772000},"page":"123516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The development and validation of sensitive LC-MS\/MS method for quantitative bioanalysis of carmofur in mouse plasma and its application to pharmacokinetic study"],"prefix":"10.1016","volume":"1212","author":[{"given":"Mohammad Mohiminul","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan F.","family":"Kub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilashini","family":"Rajaratnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shama P.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123516_b0005","first-page":"77","article-title":"Postoperative adjuvant use of carmofur for early breast cancer","volume":"49","author":"Morimoto","year":"2003","journal-title":"Osaka City Med. J."},{"key":"10.1016\/j.jchromb.2022.123516_b0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/hed.2880120506","article-title":"Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas","volume":"12","author":"Nakashima","year":"1990","journal-title":"Head Neck"},{"key":"10.1016\/j.jchromb.2022.123516_b0015","unstructured":"M. Ikeda, K. Teshima, K. Noda, S. Yamagata, T. Sugawa, S. Okamura, H. Kubo, O. Sugimoto, H. Nakajima, T. Yamabe, et al., [Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association], Gan to Kagaku Ryoho [Jap J Cancer Chemoth], 21 (1994) 1967-1974."},{"key":"10.1016\/j.jchromb.2022.123516_b0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/oxfordjournals.annonc.a057861","article-title":"Short report: Phase II trial of oral carmofur in advanced pancreatic carcinoma","volume":"2","author":"Kajanti","year":"1991","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jchromb.2022.123516_b0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000421-199012000-00005","article-title":"Oral Carmofur in Advanced Gastrointestinal Cancer","volume":"13","author":"Gr\u00f6hn","year":"1990","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.jchromb.2022.123516_b0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/cancers12040937","article-title":"Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments","volume":"12","author":"Rajaratnam","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jchromb.2022.123516_b0035","unstructured":"M.M. Islam, S.P. Mirza, Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacology, Drug Dev Res, DOI 10.1002\/ddr.21984(2022)."},{"key":"10.1016\/j.jchromb.2022.123516_b0040","doi-asserted-by":"crossref","first-page":"24753","DOI":"10.18632\/oncotarget.15800","article-title":"Acid ceramidase is a novel drug target for pediatric brain tumors","volume":"8","author":"Doan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jchromb.2022.123516_b0045","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3892\/or.2017.5855","article-title":"Acid ceramidase confers radioresistance to glioblastoma cells","volume":"38","author":"Doan","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jchromb.2022.123516_b0050","doi-asserted-by":"crossref","first-page":"112662","DOI":"10.18632\/oncotarget.22637","article-title":"Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency","volume":"8","author":"Doan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jchromb.2022.123516_b0055","doi-asserted-by":"crossref","unstructured":"Y. Li, Y. Xu, B.A. Benitez, M.S. Nagree, J.T. Dearborn, X. Jiang, M.A. Guzman, J.C. Woloszynek, A. Giaramita, B.K. Yip, J. Elsbernd, M.C. Babcock, M. Lo, S.C. Fowler, D.F. Wozniak, C.A. Vogler, J.A. Medin, B.E. Crawford, M.S. Sands, Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target, Proceedings of the National Academy of Sciences of the United States of America, 116 (2019) 20097-20103.","DOI":"10.1073\/pnas.1912108116"},{"key":"10.1016\/j.jchromb.2022.123516_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jchromb.2022.123516_b0065","doi-asserted-by":"crossref","unstructured":"K. Wu, Y. Xiu, P. Zhou, Y. Qiu, Y. Li, A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities, Frontiers in Pharmacology, 10 (2019) 818-818.","DOI":"10.3389\/fphar.2019.00818"},{"key":"10.1016\/j.jchromb.2022.123516_b0070","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/hmg\/ddy105","article-title":"Acid ceramidase inhibition ameliorates \u03b1-synuclein accumulation upon loss of GBA1 function","volume":"27","author":"Kim","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jchromb.2022.123516_b0075","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1535-7163.MCT-17-1185","article-title":"Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma","volume":"17","author":"Donson","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jchromb.2022.123516_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/foy119","article-title":"Pharmacological inhibition of pigmentation in Cryptococcus","volume":"19","author":"Zimbres","year":"2019","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.jchromb.2022.123516_b0085","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/AAC.00377-16","article-title":"Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms","volume":"60","author":"Torres","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2022.123516_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(00)81177-9","article-title":"Determination of 1-hexylcarbamoyl-5-fluorouracil and its metabolites in biomedical specimens by high-performance liquid chromatography","volume":"163","author":"Kono","year":"1979","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123516_b0095","doi-asserted-by":"crossref","unstructured":"M. ligo, A. Nakamura, K. kuretani, A. Hoshi, Excretion of 1-hexylcarbamoyl-5-fluorouracil in urine of mice, Journal of Pharmacobio-Dynamics, 4 (1981) 490-496.","DOI":"10.1248\/bpb1978.4.490"},{"key":"10.1016\/j.jchromb.2022.123516_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00498258109045272","article-title":"Metabolism of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a new antitumour agent, in rats, rabbits and dogs","volume":"11","author":"Kobari","year":"1981","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2022.123516_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-4347(00)80247-9","article-title":"Quantitative determination of 1-hexylcarbamoyl-5-fluorouracil and its metabolites in man","volume":"225","author":"Nakajima","year":"1981","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123516_b0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1248\/bpb1978.2.5","article-title":"Distribution of 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil by oral administration in mice","volume":"2","author":"Iigo","year":"1979","journal-title":"Journal of Pharmacobio-Dynamics"},{"key":"10.1016\/j.jchromb.2022.123516_b0115","unstructured":"FDA, Bioanalytical Method Validation Guidance for Industry, in: U.S.D.o.H.a.H. Services (Ed.), 2018."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222004214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222004214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:09:40Z","timestamp":1761606580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222004214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"alternative-id":["S1570023222004214"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123516","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development and validation of sensitive LC-MS\/MS method for quantitative bioanalysis of carmofur in mouse plasma and its application to pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123516"}}